2027 ICD-10-CM Diagnosis Code T45.623SPoisoning by hemostatic drug, assault, sequela
T45.623S is a billable ICD-10-CM diagnosis code for poisoning by hemostatic drug, assault, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.
Code Identity
Code Classification
Present on Admission (POA)Billing
T45.623S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review the other POA exempt codes in Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50).
Coding GuidelinesGuidance
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified (T45). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to T45.623S: its own notes plus those printed at T45, block T36-T50, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.
Includes
Further defines, or gives examples of, the content of the category.
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
Code First
The underlying condition named in the note is sequenced before this code.
Use Additional Code
Add a second code, after this one, to fully describe the condition.
- code to identify any retained foreign body, if applicable (Z18.-)
Notes
General instructions on how these codes are used.
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
7th Character
Every code in the category takes a 7th character from the listed values, with the placeholder X filling any empty positions before it.
- The appropriate 7th character is to be added to each code from category T45
- Ainitial encounter
- Dsubsequent encounter
- Ssequela this code
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Aminocaproic Acid
an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.Aprotinin
a single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. it is an inhibitor of proteolytic enzymes including chymotrypsin; kallikrein; plasmin; and trypsin. it is used in the treatment of hemorrhage associated with raised plasma concentrations of plasmin. it is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with extracorporeal circulation. (reynolds jef(ed): martindale: the extra pharmacopoeia (electronic version). micromedex, inc, englewood, co, 1995)Hemostatics
agents acting to arrest the flow of blood. absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. these agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.Tranexamic Acid
antifibrinolytic hemostatic used in severe hemorrhage.
Table of Drugs and ChemicalsClinical
Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.
| Substance | Accidental | Self-harm | Assault | Undetermined | Adverse Effect | Underdosing |
|---|---|---|---|---|---|---|
| Aminocaproic acid | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Antifibrinolytic drug | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Aprotinin | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Epsilon amino-caproic acid | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Fibrinolysis::inhibitor NEC | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Hemostatic | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Hemostatic::drug, systemic | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Inhibitor::fibrinolysis | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
| Tranexamic acid | T45.621 | T45.622 | T45.623 | T45.624 | T45.625 | T45.626 |
Patient EducationClinical
Poisoning
A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert T45.623S to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About T45.623SOverview
What is the ICD-10 code for poisoning by hemostatic drug, assault, sequela?
The ICD-10-CM code for poisoning by hemostatic drug, assault, sequela is T45.623S (sometimes written as T45623S). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is T45.623S (Poisoning by hemostatic drug, assault) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by hemostatic drug, assault, sequela on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What does the 7th character S in T45.623S mean?
The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by hemostatic drug, assault itself has resolved, not the original event.
What MS-DRG does T45.623S group to?
When poisoning by hemostatic drug, assault, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 923, 922, with relative weights from 0.9980 to 1.6248 depending on complications. Higher weights mean higher Medicare reimbursement.
Is T45.623S exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by hemostatic drug, assault, sequela on inpatient claims. The code appears in the Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50) range of the CMS exempt list.
